GlassScriptPhysician profile
Gregory A Flermoen
NPI 1508178682
$5,493.42
in general payments reported to CMS, 2019-2025
19 companies · $4,540 in 2025
The $4,540 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.66 · 2020: $66.94 · 2022: $352 · 2023: $287 · 2024: $193 · 2025: $4,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,531 · Travel and Lodging: $1,765 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,531.15 |
| Travel and Lodging | $1,764.61 |
| Food and Beverage | $723.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,467.36 | 2020-2025 | |
| Hologic Sales and Service, LLC | $199.31 | 2022-2023 | Coolseal Generator |
| Medtronic, INC. | $151.86 | 2023-2025 | V-Loc 180, Transorb, Progrip |
| Smith+Nephew, INC. | $110.74 | 2023-2025 | Stravix, Renasys Touch, Grafix Pl |
| Baxter Healthcare | $93.27 | 2023-2025 | Perclot, Floseal |
| Heron Therapeutics, INC. | $65.27 | 2022-2025 | Zynrelef |
| Kerecis Limited | $64.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $56.41 | 2019-2025 | Stratafix |
| Vertex Pharmaceuticals Incorporated | $46.91 | 2025 | |
| Pfizer INC. | $32.09 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.15 | 2024-2025 | Gattex |
| Integra Lifesciences Corporation | $28.25 | 2022 | |
| Convatec INC. | $25.57 | 2023 | |
| Edwards Lifesciences Corporation | $24.66 | 2019 | |
| Hartmann USA, INC. | $22.92 | 2025 | Zetuvit Plus 10x10 P10 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.83 | 2023 | Quikclot |
| Verity Pharmaceuticals INC. | $18.89 | 2025 | Tlando |
| Endogastric Solutions, INC | $18.45 | 2024 | Esophyx |
| Antares Pharma, INC. | $15.10 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Flermoen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.